Neuberger Berman Group »

Biosante Pharmaceuticals shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $302k 5.5k 55.28
2024-09-30 $331k 5.5k 59.66
2024-06-30 $352k 5.5k 63.68

More positions owned by Neuberger Berman Group

January 25 Calls on PLTR US Option Call Option (PLTR)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Nvidia Corp Common (NVDA)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc-cl C Common (GOOG)
Alphabet Inc Class A A Common (GOOGL)
T Mobile Us Common (TMUS)
Home Depot Common (HD)
Meta Platforms Inc Class A A Common (META)
Berkshire Hathaway Inc Class B B Common (BRK.B)
Eli Lilly & Co Common (LLY)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Goldman Sachs Group
Dimensional Fund Advisors
Global Alpha Capital Management
Citadel Advisors
UBS Group
Ranger Investment Management
Macquarie Group
Deep Track Capital
William Blair Investment Management
Geode Capital Management
Tang Capital Management

View all funds holding Biosante Pharmaceuticals